0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Electrocardiographic abnormalities in patients with cardiomyopathies

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Abnormalities in impulse generation and transmission are among the first signs of cardiac remodeling in cardiomyopathies. Accordingly, 12-lead electrocardiogram (ECG) of patients with cardiomyopathies may show multiple abnormalities. Some findings are suggestive of specific disorders, such as the discrepancy between QRS voltages and left ventricular (LV) mass for cardiac amyloidosis or the inverted T waves in the right precordial leads for arrhythmogenic cardiomyopathy. Other findings are less sensitive and/or specific, but may orient toward a specific diagnosis in a patient with a specific phenotype, such as an increased LV wall thickness or a dilated LV. A “cardiomyopathy-oriented” mindset to ECG reading is important to detect the possible signs of an underlying cardiomyopathy and to interpret correctly the meaning of these alterations, which differs in patients with cardiomyopathies or other conditions.

          Graphical abstract

          Supplementary Information

          The online version contains supplementary material available at 10.1007/s10741-023-10358-7.

          Related collections

          Most cited references91

          • Record: found
          • Abstract: not found
          • Article: not found

          2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.

            Most studies of amyloidotic cardiomyopathy consider as a single entity the 3 main systemic cardiac amyloidoses: acquired monoclonal immunoglobulin light-chain (AL); hereditary, mutated transthyretin-related (ATTRm); and wild-type transthyretin-related (ATTRwt). In this study, we compared the diagnostic/clinical profiles of these 3 types of systemic cardiac amyloidosis. We conducted a longitudinal study of 233 patients with clear-cut diagnosis by type of cardiac amyloidosis (AL, n=157; ATTRm, n=61; ATTRwt, n=15) at 2 large Italian centers providing coordinated amyloidosis diagnosis/management facilities since 1990. Average age at diagnosis was higher in AL than in ATTRm patients; all ATTRwt patients except 1 were elderly men. At diagnosis, mean left ventricular wall thickness was higher in ATTRwt than in ATTRm and AL. Left ventricular ejection fraction was moderately depressed in ATTRwt but not in AL or ATTRm. ATTRm patients less often displayed low QRS voltage (25% versus 60% in AL; P<0.0001) or low voltage-to-mass ratio (1.1+/-0.5 versus 0.9+/-0.5; P<0.0001). AL patients appeared to have greater hemodynamic impairment. On multivariate analysis, ATTRm was a strongly favorable predictor of survival, and ATTRwt predicted freedom from major cardiac events. AL, ATTRm, and ATTRwt should be considered 3 different cardiac diseases, probably characterized by different pathophysiological substrates and courses. Awareness of the diversity underlying the cardiac amyloidosis label is important on several levels, ranging from disease classification to diagnosis and clinical management.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria

                Bookmark

                Author and article information

                Contributors
                albertoaimo@libero.it
                Journal
                Heart Fail Rev
                Heart Fail Rev
                Heart Failure Reviews
                Springer US (New York )
                1382-4147
                1573-7322
                17 October 2023
                17 October 2023
                2024
                : 29
                : 1
                : 151-164
                Affiliations
                [1 ]Interdisciplinary Center for Health Sciences, Scuola Superiore Sant’Anna, ( https://ror.org/025602r80) Pisa, Italy
                [2 ]Cardiology Division, Fondazione Toscana Gabriele Monasterio, ( https://ror.org/058a2pj71) Pisa, Italy
                [3 ]Cardiology Unit, Bentivoglio Hospital, Bologna, Italy
                [4 ]Center for Diagnosis and Management of Cardiomyopathies, Cardiothoracovascular Department Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) and University of Trieste, ( https://ror.org/02n742c10) Trieste, Italy
                [5 ]GRID grid.24704.35, ISNI 0000 0004 1759 9494, Careggi University Hospital, ; Florence, Italy
                [6 ]Department of Experimental and Clinical Medicine, University of Florence, Meyer Children Hospital Florence, ( https://ror.org/04jr1s763) Florence, Italy
                [7 ]GRID grid.439338.6, ISNI 0000 0001 1114 4366, Royal Brompton and Harefield Hospital, ; London, UK
                [8 ]GRID grid.264200.2, ISNI 0000 0000 8546 682X, St George’s University of London, ; London, UK
                [9 ]GRID grid.416353.6, ISNI 0000 0000 9244 0345, UCL Centre for Heart Muscle Disease and Lead of the Inherited Cardiovascular Disease Unit, , Bart’s Heart Centre, ; London, UK
                [10 ]Cardiology Centre, University of Ferrara, ( https://ror.org/041zkgm14) Ferrara, Italy
                Author information
                http://orcid.org/0000-0001-9129-9519
                Article
                10358
                10.1007/s10741-023-10358-7
                10904564
                37848591
                e04cff5d-fb1c-495e-915a-5b85beb510a8
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 3 October 2023
                Funding
                Funded by: Scuola Superiore Sant'Anna
                Categories
                Article
                Custom metadata
                © Springer Science+Business Media, LLC, part of Springer Nature 2024

                Cardiovascular Medicine
                ecg,electrocardiogram,cardiomyopathy,hypertrophic cardiomyopathy,amyloidosis

                Comments

                Comment on this article